Jennifer Harrington
Family · Las Vegas, NVNPI 1548612526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 46.4% of the total. Reporting peaked in 2023 at $781 and has fallen 84.2% since, to $124 in 2025.
Across 134 payments — averaging $17.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$246
- Pfizer$193
- Amgen$108
- AstraZeneca$78
- Boehringer Ingelheim$57
- plus $581 from 22 others
What the payments were for
- Food & beverage$2,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $1,094 |
| GSK | 17 | $246 |
| Pfizer | 11 | $193 |
| Amgen | 5 | $108 |
| AstraZeneca | 5 | $78 |
| Boehringer Ingelheim | 4 | $57 |
| Bayer | 3 | $54 |
| Abiomed | 2 | $48 |
| Abbott | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Merck | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Johnson & Johnson | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Novo Nordisk | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| Vertex | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Axonics, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
How this compares
$2,356 in reported general payments places this provider in the 85th percentile of 1,501 family providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 12 | $833 |
| Atorvastatin Calcium | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other family in Las Vegas
- Hollie TylerLas Vegas$118K
- John PhoenixLas Vegas$107K
- Jon FaillaLas Vegas$74K
- Alex LapasaranLas Vegas$50K
- Erin WilkinsonLas Vegas$43K
- Anna Melisa Lopez-SanglayLas Vegas$42K
- Kelly PapeshLas Vegas$28K
- Bernard BlanksLas Vegas$26K
- Hillary DursteinLas Vegas$21K
- Victoria HughesLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.